NO308826B1 - Inhibering av glattmusklet cellemigrering med (R)-amlodipin - Google Patents

Inhibering av glattmusklet cellemigrering med (R)-amlodipin

Info

Publication number
NO308826B1
NO308826B1 NO960730A NO960730A NO308826B1 NO 308826 B1 NO308826 B1 NO 308826B1 NO 960730 A NO960730 A NO 960730A NO 960730 A NO960730 A NO 960730A NO 308826 B1 NO308826 B1 NO 308826B1
Authority
NO
Norway
Prior art keywords
pct
amlodipine
smooth muscle
cell migration
muscle cell
Prior art date
Application number
NO960730A
Other languages
English (en)
Norwegian (no)
Other versions
NO960730L (no
NO960730D0 (no
Inventor
Suresh Babubhai Chahwala
Derek Paul Winslow
Original Assignee
Pfizer Res And Dev Co Nv Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10741080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO308826(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res And Dev Co Nv Sa filed Critical Pfizer Res And Dev Co Nv Sa
Publication of NO960730L publication Critical patent/NO960730L/no
Publication of NO960730D0 publication Critical patent/NO960730D0/no
Publication of NO308826B1 publication Critical patent/NO308826B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO960730A 1993-08-26 1996-02-23 Inhibering av glattmusklet cellemigrering med (R)-amlodipin NO308826B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939317773A GB9317773D0 (en) 1993-08-26 1993-08-26 Therapeutic compound
PCT/EP1994/002697 WO1995005822A1 (fr) 1993-08-26 1994-08-10 Inhibition de la migration cellulaire de la fibre lisse par la (r)-amlodipine

Publications (3)

Publication Number Publication Date
NO960730L NO960730L (no) 1996-02-23
NO960730D0 NO960730D0 (no) 1996-02-23
NO308826B1 true NO308826B1 (no) 2000-11-06

Family

ID=10741080

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960730A NO308826B1 (no) 1993-08-26 1996-02-23 Inhibering av glattmusklet cellemigrering med (R)-amlodipin

Country Status (20)

Country Link
US (1) US6080761A (fr)
EP (1) EP0754043B1 (fr)
JP (2) JP3007992B2 (fr)
KR (1) KR0163840B1 (fr)
CN (1) CN1060039C (fr)
AT (1) ATE192337T1 (fr)
AU (1) AU686658B2 (fr)
CA (1) CA2170278C (fr)
DE (1) DE69424317T2 (fr)
DK (1) DK0754043T3 (fr)
ES (1) ES2145149T3 (fr)
GB (1) GB9317773D0 (fr)
GR (1) GR3033547T3 (fr)
IL (1) IL110700A (fr)
NO (1) NO308826B1 (fr)
NZ (1) NZ271993A (fr)
PT (1) PT754043E (fr)
TW (1) TW470646B (fr)
WO (1) WO1995005822A1 (fr)
ZA (1) ZA946475B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129265B2 (en) * 1999-04-23 2006-10-31 Mason R Preston Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
GB0020842D0 (en) * 2000-08-23 2000-10-11 Pfizer Ltd Therapeutic compositions
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
EP1345901A2 (fr) * 2000-12-29 2003-09-24 Bioorganics B.V. Procede de fabrication de l'amlodipine, derives de l'amlodipine et precurseurs associes
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
CN1152013C (zh) * 2001-11-22 2004-06-02 张喜田 一类左旋氨氯地平盐的水合物及其制剂
US7858801B2 (en) * 2004-10-20 2010-12-28 Emcure Pharmaceuticals Limited Process for producing enantiomer of amlodipine in high optical purity
KR100828883B1 (ko) * 2006-10-27 2008-05-09 씨제이제일제당 (주) 라세믹 암로디핀으로부터 ｓ-(-)-암로디핀의 분리방법
KR100830003B1 (ko) * 2006-10-31 2008-05-15 씨제이제일제당 (주) 결정성 ｓ-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804630D0 (en) * 1988-02-27 1988-03-30 Pfizer Ltd Preparation of r-& s-amlodipine
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine

Also Published As

Publication number Publication date
EP0754043A1 (fr) 1997-01-22
KR0163840B1 (ko) 1998-12-01
ATE192337T1 (de) 2000-05-15
EP0754043B1 (fr) 2000-05-03
JP3007992B2 (ja) 2000-02-14
NO960730L (no) 1996-02-23
DE69424317T2 (de) 2000-08-24
KR960703593A (ko) 1996-08-31
AU7612994A (en) 1995-03-21
JPH08509004A (ja) 1996-09-24
CN1060039C (zh) 2001-01-03
DE69424317D1 (de) 2000-06-08
AU686658B2 (en) 1998-02-12
JP2000044475A (ja) 2000-02-15
ZA946475B (en) 1996-02-26
PT754043E (pt) 2000-09-29
NZ271993A (en) 1997-11-24
TW470646B (en) 2002-01-01
NO960730D0 (no) 1996-02-23
CA2170278A1 (fr) 1995-03-02
DK0754043T3 (da) 2000-08-07
GR3033547T3 (en) 2000-09-29
ES2145149T3 (es) 2000-07-01
IL110700A (en) 1999-04-11
WO1995005822A1 (fr) 1995-03-02
CA2170278C (fr) 1999-08-03
GB9317773D0 (en) 1993-10-13
US6080761A (en) 2000-06-27
CN1129907A (zh) 1996-08-28
IL110700A0 (en) 1994-11-11

Similar Documents

Publication Publication Date Title
DK0675714T3 (da) Kombination af en cholesterol-biosynteseinhibitor og en beta-lactam-cholesterolabsorptionsinhibitor
NO960730D0 (no) Inhibering av glattmusklet cellemigrering med (R)-amlodipin
ZA969880B (en) Flame inhibitor composition and method of application
DK0754059T3 (da) Anvendelige fremgangsmåder og sammensætninger til hæmning af angiogenese
EP0693083A4 (fr) Derives de l'alphacetoamide utiles comme inhibiteurs de thrombose
NO972043D0 (no) Tienopyridin eller tienopyrimidinderivater og deres anvendelse
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
EP0651766A4 (fr) INHIBITEURS DU FACTEUR Xa, DERIVES DE L'INHIBITEUR DE TRYPSINE PANCREATIQUE BOVINE.
EP0671944A4 (fr) Inhibiteurs de complexe facteur viia-thromboplastine tissulaire derives d'un inhibiteur de trypsine pancreatique de bovin.
IT1259419B (it) Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
DK0773320T3 (da) Sikkerhedsark med i det væsentlige konstant tykkelse
PL326294A1 (en) Method of retarding the inhibitor 1 of plasminogene activator
NO965497L (no) Fremgangsmåte for kontrollert fiksering av avleiringsinhibitor i en underjordisk formasjon
NO963469D0 (no) Substituert amidin-derivat og aggregasjonsblokkerer som inneholder dette
PT882398E (pt) Inibidor de crescimento de thiobacillus thiooxidans
DE69609823D1 (de) Verfahren zur inhibierung der zersetzung von 1,1,1,2,3,3-hexafluorpropan und 1,1,1,3,3-pentafluorpropan und zersetzungsinhibitor
EP0451436A3 (en) Method of curing and preventing obesity by alpha-amylase inhibitor
DK0971714T3 (da) Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens
AU5051090A (en) A method of treatment or prevention of post-PTCA restenosis by post-PTCA restenosis inhibitor
NO950943D0 (no) Metode for maskinell individuell sensorstyrt kopiering av tömmer for bygging av laftede bygninger